RAPT Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2025 | 22.35 M | $35.32 M | 100.00% | 57.46% |
ORBIMED ADVISORS LLC | 02/14/2025 | 13.14 M | $20.75 M | 100.00% | 33.76% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 13.14 M | $19.75 M | 100.00% | 33.76% |
FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 12.50 M | $19.75 M | 100.00% | 32.13% |
RTW INVESTMENTS, LP | 02/14/2025 | 11.76 M | $18.59 M | 100.00% | 30.24% |
BVF INC/IL | 02/14/2025 | 9.24 M | $14.60 M | 100.00% | 23.74% |
REDMILE GROUP, LLC | 02/14/2025 | 6.48 M | $10.23 M | 1,183.43% | 16.64% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 6.01 M | $9.50 M | 100.00% | 15.45% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 5.88 M | $9.29 M | 100.00% | 15.11% |
FMR LLC | 02/13/2025 | 5.23 M | $8.27 M | -0.05% | 13.45% |
VANGUARD GROUP INC | 02/11/2025 | 2.94 M | $4.65 M | -6.80% | 7.56% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.30 M | $3.63 M | -8.00% | 5.91% |
COLUMN GROUP LLC | 02/14/2025 | 1.33 M | $2.10 M | -50.44% | 3.42% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.24 M | $1.96 M | 100.00% | 3.20% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 1.17 M | $1.86 M | 15,557.51% | 3.02% |
AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 1.00 M | $1.58 M | 100.00% | 2.57% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 862,886 | $1.36 M | 2.46% | 2.22% |
FEDERATED HERMES, INC. | 02/13/2025 | 802,618 | $1.27 M | 0.33% | 2.06% |
D. E. SHAW & CO., INC. | 02/14/2025 | 770,013 | $1.22 M | -26.54% | 1.98% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 737,704 | $1.17 M | -23.15% | 1.90% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 716,937 | $1.13 M | 4.94% | 1.84% |
EUCLIDEAN CAPITAL LLC | 02/14/2025 | 657,899 | $1.04 M | 0.00% | 1.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/14/2025 | 575,000 | $908,500 | -66.67% | 1.48% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 503,700 | $795,846 | -28.55% | 1.29% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 486,948 | $769,378 | 22.42% | 1.25% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 369,736 | $584,183 | 25.50% | 0.95% |
DEUTSCHE BANK AG\ | 02/14/2025 | 276,170 | $436,349 | -3.25% | 0.71% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 219,997 | $347,595 | 9.21% | 0.57% |
JPMORGAN CHASE & CO | 02/12/2025 | 205,164 | $324,158 | 1,128.31% | 0.53% |
CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 200,000 | $316,000 | -59.74% | 0.51% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 180,465 | $285,135 | -65.32% | 0.46% |
UBS GROUP AG | 02/14/2025 | 149,669 | $236,477 | 418.86% | 0.38% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 148,823 | $235,233 | -41.42% | 0.38% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 125,000 | $197,500 | 66.67% | 0.32% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 125,000 | $197,500 | 100.00% | 0.32% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 116,925 | $184,741 | 50.47% | 0.30% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 90,144 | $142,428 | -0.07% | 0.23% |
EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 89,076 | $140,740 | 0.00% | 0.23% |
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 02/14/2025 | 73,383 | $115,945 | 100.00% | 0.19% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 70,979 | $112,147 | 0.05% | 0.18% |
HAP TRADING, LLC | 02/13/2025 | 62,500 | $26,563 | 100.00% | 0.16% |
CALLAN FAMILY OFFICE, LLC | 02/07/2025 | 58,040 | $91,703 | 100.00% | 0.15% |
SHAY CAPITAL LLC | 02/14/2025 | 51,300 | $81,054 | 100.00% | 0.13% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 50,710 | $80,122 | 0.00% | 0.13% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 49,011 | $77,437 | 344.34% | 0.13% |
ALGERT GLOBAL LLC | 02/14/2025 | 47,483 | $75,000 | 0.00% | 0.12% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 47,053 | $74,344 | -1.82% | 0.12% |
RHUMBLINE ADVISERS | 01/30/2025 | 46,193 | $72,975 | 0.00% | 0.12% |
JASPER RIDGE PARTNERS, L.P. | 02/14/2025 | 45,650 | $72,127 | 0.00% | 0.12% |
BARCLAYS PLC | 02/13/2025 | 45,203 | $71,000 | 13.78% | 0.12% |
RAPT Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 132 institutional investors and hedge funds held shares of RAPT Therapeutics, Inc.. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 22.35 M
ORBIMED ADVISORS LLC: 13.14 M
TCG Crossover Management, LLC: 13.14 M
Foresite Capital Management VI LLC: 12.5 M
RTW INVESTMENTS, LP: 11.76 M
BVF INC/IL: 9.24 M
325.91% of RAPT Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 136.78 M shares in the last 24 months. This purchase volume represents approximately $235.26 M in transactions.